arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

COMPASS Pathways plc

CMPS
$13.75 ▼ -1.03 (-6.97%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
8 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Bullish
auto_awesome

Analytical Summary

COMPASS Pathways plc shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.3B
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC 836.7% ↗
FCF / Share $-1.68 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -0.60
info Valuation on last close. End-of-day price, Sep 23, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-287.86M
↓ -85.6% —
FCF / Share Free cash flow per share
$-1.68
↑ +4.8% —
Long-Term Debt Long-term obligations
$31.63M
↑ +4.9% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Financial Health ↑
60
Cash Quality ↓
42

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 27 quarters